Insomnia is a persistent difficulty initiating sleep, maintaining sleep, or achieving restorative sleep, occurring despite adequate opportunity to sleep. It is not merely “feeling tired”; it reflects dysregulation of sleep-wake biology involving hyperarousal, circadian misalignment, and maladaptive behavioral and cognitive patterns. Insomnia can present acutely (days to weeks) following stressors or can become chronic when predisposing, precipitating, and perpetuating factors interact over months.
A key mechanism is hyperarousal. In insomnia, the brain’s arousal systems remain activated: sympathetic tone may be elevated, cortical and subcortical networks show increased wake-like activity at night, and stress-response pathways (including hypothalamic-pituitary-adrenal signaling) can remain sensitized. Cognitive arousal is equally important—rumination about sleep loss, fear of not sleeping, and performance pressure can create a self-reinforcing loop. This is captured by cognitive models such as the Spielman 3P model (predisposing vulnerability, precipitating events, perpetuating factors) and perpetuating-factor frameworks that emphasize conditioned wakefulness.
Conditioned arousal explains why “more effort” to sleep can backfire. When individuals spend extra time in bed trying to force sleep, the bed and bedtime cues become associated with wakefulness and threat appraisal. Over time, the bed shifts from a safety signal to a conditioned stimulus that triggers alertness. The result is decreased sleep efficiency and increased sleep-onset latency, often accompanied by fragmented sleep and early morning awakenings. Thus, insomnia is partly a learning disorder: behavior and attention patterns stabilize wakefulness.
Circadian misalignment can further worsen symptoms. Light exposure at inappropriate times, irregular schedules, and late-night screen use can shift circadian phase. When endogenous circadian drive for sleep does not align with the behavioral sleep window, sleep becomes lighter and more discontinuous. People may then compensate by extending time in bed or trying to “catch up,” which can strengthen maladaptive sleep timing.
Sleep tracking technology promises objectivity but can contribute to insomnia maintenance in some users. Wearables often estimate sleep stages using accelerometry and heart-rate proxies rather than electroencephalography. Metrics like “time in bed,” “sleep efficiency,” or “REM percentage” can be misleading, especially when motion artifacts, breathing variation, and algorithmic assumptions differ across individuals. If users fixate on unfavorable nightly numbers, they may increase performance pressure, intensify rumination, and interpret normal variability as pathology. This can resemble the same behavioral mechanism as trying harder to sleep: heightened attention to sleep becomes a trigger for hyperarousal.
Evidence-based treatment prioritizes interrupting conditioned arousal and aligning sleep timing. Cognitive behavioral therapy for insomnia (CBT-I) is first-line and typically includes stimulus control (using the bed only for sleep and sex; leaving the bedroom if unable to sleep), sleep restriction therapy (temporarily limiting time in bed to consolidate sleep, then gradually extending), cognitive restructuring (reducing catastrophic beliefs about sleep loss), and relaxation or attentional training. These interventions aim to reduce sleep-related threat and restore homeostatic and circadian function.
Pharmacotherapy can be appropriate for select patients but is generally best integrated with behavioral strategies. Short-term use of hypnotics may reduce symptoms while CBT-I builds durable change. However, risks include tolerance, dependence potential (with certain agents), next-day sedation, falls in older adults, and complex sleep behaviors in some populations. Medications also do not address the learned hyperarousal loop directly, which is why CBT-I often yields longer-lasting benefits.
Sleep hygiene advice—consistent wake time, adequate morning light, limiting caffeine and alcohol near bedtime, reducing late evening screens, and maintaining a comfortable sleep environment—is helpful but often insufficient alone for chronic insomnia. Hygiene works best as a supplement to CBT-I rather than a standalone solution.
Clinically, insomnia warrants assessment for comorbidities that perpetuate sleep disruption: anxiety and depressive disorders, restless legs syndrome, obstructive sleep apnea, chronic pain, gastroesophageal reflux, substance use, and medication side effects. Secondary insomnia often improves when underlying causes are treated. For example, treating sleep apnea with continuous positive airway pressure can dramatically improve sleep continuity and daytime function.
When insomnia is accompanied by severe daytime impairment, mood deterioration, or suicidal ideation, urgent evaluation is essential. Patients should also seek medical assessment if symptoms persist beyond three months, if loud snoring or witnessed apneas occur, or if nocturnal movements suggest restless legs.
In summary, insomnia arises from interacting neurobiological arousal, circadian timing, and maladaptive learning. Trying harder to sleep can intensify conditioned wakefulness, while sleep tracking can inadvertently amplify performance monitoring and rumination when metrics are interpreted rigidly. The most evidence-backed response is CBT-I, complemented by targeted evaluation of comorbid sleep disorders and careful, non-obsessive optimization of sleep timing and environment. Source: TheEconomist
The Economist: Unlike trying to eat healthily or exercise, putting more thought and effort into sleeping can backfire. Yet sleep tracking is not the only answer. #breaking
— @TheEconomist May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
